|
|
Article: Hope for therapeutics based on cancer vaccines as number of treatments are close to FDA approval or in late stage clinical trials.
- Article from:
- M2 Presswire
- Article date:
- April 19, 2004
CopyrightCOPYRIGHT 2004 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-19 April 2004-Research and Markets: Hope for therapeutics based on cancer vaccines as number of treatments are close to FDA approval or in late stage clinical trials(C)1994-2004 M2 COMMUNICATIONS LTD
RDATE:04182004
Research and Markets announces the addition of this new report entitled "Analytical Tool - Emerging Therapeutics Based on Cancer Vaccines" to its offerings.
The concept of utilizing the immune system for the treatment of cancer has been tried for some time without any direct breakthrough success. So far "passive" immunotherapy has experienced most success, with antibody and cytokine therapy leading the way. There are, ...